Overview

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
Gabapentin and pregabalin are treatments for some types of neuropathic pain, including postherpetic neuralgia (PHN). However, these treatments usually need to be taken 3 times a day for effective pain control. The purpose of this study is to determine whether a new gabapentin tablet, which only needs to be taken once a day, is safe and effective for the treatment of postherpetic neuralgia.
Phase:
Phase 3
Details
Lead Sponsor:
Depomed
Treatments:
Gabapentin
gamma-Aminobutyric Acid